TY - JOUR AU - Verkerk, A. J. AU - Pieretti, M. AU - Sutcliffe, J. S. AU - Fu, Y. H. AU - Kuhl, D. P. AU - Pizzuti, A. PY - 1991 DA - 1991// TI - Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome JO - Cell VL - 65 UR - https://doi.org/10.1016/0092-8674(91)90397-H DO - 10.1016/0092-8674(91)90397-H ID - Verkerk1991 ER - TY - JOUR AU - Song, F. J. AU - Barton, P. AU - Sleightholme, V. AU - Yao, G. L. AU - Fry-Smith, A. PY - 2003 DA - 2003// TI - Screening for fragile X syndrome: a literature review and modelling study JO - Health Technol Assess VL - 7 UR - https://doi.org/10.3310/hta7160 DO - 10.3310/hta7160 ID - Song2003 ER - TY - JOUR AU - Hunter, J. AU - Rivero-Arias, O. AU - Angelov, A. AU - Kim, E. AU - Fotheringham, I. AU - Leal, J. PY - 2014 DA - 2014// TI - Epidemiology of fragile X syndrome: a systematic review and meta-analysis JO - Am J Med Genet A VL - 164A UR - https://doi.org/10.1002/ajmg.a.36511 DO - 10.1002/ajmg.a.36511 ID - Hunter2014 ER - TY - JOUR AU - Berry-Kravis, E. AU - Knox, A. AU - Hervey, C. PY - 2011 DA - 2011// TI - Targeted treatments for fragile X syndrome JO - J Neurodev Disord VL - 3 UR - https://doi.org/10.1007/s11689-011-9074-7 DO - 10.1007/s11689-011-9074-7 ID - Berry-Kravis2011 ER - TY - JOUR AU - Gross, C. AU - Berry-Kravis, E. M. AU - Bassell, G. J. PY - 2012 DA - 2012// TI - Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond JO - Neuropsychopharmacology VL - 37 UR - https://doi.org/10.1038/npp.2011.137 DO - 10.1038/npp.2011.137 ID - Gross2012 ER - TY - JOUR AU - Hagerman, R. J. AU - Berry-Kravis, E. AU - Kaufmann, W. E. AU - Ono, M. Y. AU - Tartaglia, N. AU - Lachiewicz, A. PY - 2009 DA - 2009// TI - Advances in the treatment of fragile X syndrome JO - Pediatrics VL - 123 UR - https://doi.org/10.1542/peds.2008-0317 DO - 10.1542/peds.2008-0317 ID - Hagerman2009 ER - TY - JOUR AU - Pieretti, M. AU - Zhang, F. P. AU - Fu, Y. H. AU - Warren, S. T. AU - Oostra, B. A. AU - Caskey, C. T. PY - 1991 DA - 1991// TI - Absence of expression of the FMR-1 gene in fragile X syndrome JO - Cell VL - 66 UR - https://doi.org/10.1016/0092-8674(91)90125-I DO - 10.1016/0092-8674(91)90125-I ID - Pieretti1991 ER - TY - JOUR AU - Sutcliffe, J. S. AU - Nelson, D. L. AU - Zhang, F. AU - Pieretti, M. AU - Caskey, C. T. AU - Saxe, D. PY - 1992 DA - 1992// TI - DNA methylation represses FMR-1 transcription in fragile X syndrome JO - Hum Mol Genet VL - 1 UR - https://doi.org/10.1093/hmg/1.6.397 DO - 10.1093/hmg/1.6.397 ID - Sutcliffe1992 ER - TY - JOUR AU - Maddalena, A. AU - Richards, C. S. AU - McGinniss, M. J. AU - Brothman, A. AU - Desnick, R. J. AU - Grier, R. E. PY - 2001 DA - 2001// TI - Technical standards and guidelines for fragile X: the first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee JO - Genet Med VL - 3 UR - https://doi.org/10.1097/00125817-200105000-00010 DO - 10.1097/00125817-200105000-00010 ID - Maddalena2001 ER - TY - JOUR AU - Dictenberg, J. B. AU - Swanger, S. A. AU - Antar, L. N. AU - Singer, R. H. AU - Bassell, G. J. PY - 2008 DA - 2008// TI - A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome JO - Dev Cell VL - 14 UR - https://doi.org/10.1016/j.devcel.2008.04.003 DO - 10.1016/j.devcel.2008.04.003 ID - Dictenberg2008 ER - TY - JOUR AU - Zalfa, F. AU - Giorgi, M. AU - Primerano, B. AU - Moro, A. AU - Penta, A. AU - Reis, S. PY - 2003 DA - 2003// TI - The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses JO - Cell VL - 112 UR - https://doi.org/10.1016/S0092-8674(03)00079-5 DO - 10.1016/S0092-8674(03)00079-5 ID - Zalfa2003 ER - TY - JOUR AU - Huber, K. M. AU - Gallagher, S. M. AU - Warren, S. T. AU - Bear, M. F. PY - 2002 DA - 2002// TI - Altered synaptic plasticity in a mouse model of fragile X mental retardation JO - Proc Natl Acad Sci U S A VL - 99 UR - https://doi.org/10.1073/pnas.122205699 DO - 10.1073/pnas.122205699 ID - Huber2002 ER - TY - JOUR AU - Bear, M. F. AU - Huber, K. M. AU - Warren, S. T. PY - 2004 DA - 2004// TI - The mGluR theory of fragile X mental retardation JO - Trends Neurosci VL - 27 UR - https://doi.org/10.1016/j.tins.2004.04.009 DO - 10.1016/j.tins.2004.04.009 ID - Bear2004 ER - TY - JOUR AU - Berry-Kravis, E. AU - Hessl, D. AU - Coffey, S. AU - Hervey, C. AU - Schneider, A. AU - Yuhas, J. PY - 2009 DA - 2009// TI - A pilot open label, single dose trial of fenobam in adults with fragile X syndrome JO - J Med Genet VL - 46 UR - https://doi.org/10.1136/jmg.2008.063701 DO - 10.1136/jmg.2008.063701 ID - Berry-Kravis2009 ER - TY - JOUR AU - Jacquemont, S. AU - Curie, A. AU - des Portes, V. AU - Torrioli, M. G. AU - Berry-Kravis, E. AU - Hagerman, R. J. PY - 2011 DA - 2011// TI - Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056 JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3001708 DO - 10.1126/scitranslmed.3001708 ID - Jacquemont2011 ER - TY - JOUR AU - Berry-Kravis, E. AU - Hessl, D. AU - Abbeduto, L. AU - Reiss, A. L. AU - Beckel-Mitchener, A. AU - Urv, T. K. PY - 2013 DA - 2013// TI - Outcome measures for clinical trials in fragile X syndrome JO - J Dev Behav Pediatr VL - 34 UR - https://doi.org/10.1097/DBP.0b013e31829d1f20 DO - 10.1097/DBP.0b013e31829d1f20 ID - Berry-Kravis2013 ER - TY - JOUR AU - Sansone, S. M. AU - Widaman, K. F. AU - Hall, S. S. AU - Reiss, A. L. AU - Lightbody, A. AU - Kaufmann, W. E. PY - 2012 DA - 2012// TI - Psychometric study of the Aberrant Behavior Checklist in fragile X syndrome and implications for targeted treatment JO - J Autism Dev Disord VL - 42 UR - https://doi.org/10.1007/s10803-011-1370-2 DO - 10.1007/s10803-011-1370-2 ID - Sansone2012 ER - TY - JOUR AU - Busner, J. AU - Targum, S. D. PY - 2007 DA - 2007// TI - The clinical global impressions scale: applying a research tool in clinical practice JO - Psychiatry VL - 4 ID - Busner2007 ER - TY - STD TI - Guy W. CGI: Clinical global impressions. ECDEU assessment manual for psychopharmacology. 1976, revised:217-222. ID - ref19 ER - TY - JOUR AU - Leigh, M. J. AU - Nguyen, D. V. AU - Mu, Y. AU - Winarni, T. I. AU - Schneider, A. AU - Chechi, T. PY - 2013 DA - 2013// TI - A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome JO - J Dev Behav Pediatr VL - 34 UR - https://doi.org/10.1097/DBP.0b013e318287cd17 DO - 10.1097/DBP.0b013e318287cd17 ID - Leigh2013 ER - TY - JOUR AU - Targum, S. D. AU - Busner, J. AU - Young, A. H. PY - 2008 DA - 2008// TI - Targeted scoring criteria reduce variance in global impressions JO - Hum Psychopharmacol VL - 23 UR - https://doi.org/10.1002/hup.966 DO - 10.1002/hup.966 ID - Targum2008 ER - TY - JOUR AU - Targum, S. D. AU - Houser, C. AU - Northcutt, J. AU - Little, J. A. AU - Cutler, A. J. AU - Walling, D. P. PY - 2013 DA - 2013// TI - A structured interview guide for global impressions: increasing reliability and scoring accuracy for CNS trials JO - Ann Gen Psychiatry VL - 12 UR - https://doi.org/10.1186/1744-859X-12-2 DO - 10.1186/1744-859X-12-2 ID - Targum2013 ER - TY - JOUR AU - Spearing, M. K. AU - Post, R. M. AU - Leverich, G. S. AU - Brandt, D. AU - Nolen, W. PY - 1997 DA - 1997// TI - Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP JO - Psychiatry Res VL - 73 UR - https://doi.org/10.1016/S0165-1781(97)00123-6 DO - 10.1016/S0165-1781(97)00123-6 ID - Spearing1997 ER - TY - JOUR AU - Haro, J. M. AU - Kamath, S. A. AU - Ochoa, S. AU - Novick, D. AU - Rele, K. AU - Fargas, A. PY - 2003 DA - 2003// TI - The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia JO - Acta Psychiatr Scand Suppl VL - 416 UR - https://doi.org/10.1034/j.1600-0447.107.s416.5.x DO - 10.1034/j.1600-0447.107.s416.5.x ID - Haro2003 ER - TY - JOUR AU - Schneider, L. S. AU - Olin, J. T. PY - 1996 DA - 1996// TI - Clinical global impressions in Alzheimer’s clinical trials JO - Int Psychogeriatr VL - 8 UR - https://doi.org/10.1017/S1041610296002645 DO - 10.1017/S1041610296002645 ID - Schneider1996 ER - TY - JOUR AU - Kadouri, A. AU - Corruble, E. AU - Falissard, B. PY - 2007 DA - 2007// TI - The improved Clinical Global Impression Scale (iCGI): development and validation in depression JO - BMC Psychiatry VL - 7 UR - https://doi.org/10.1186/1471-244X-7-7 DO - 10.1186/1471-244X-7-7 ID - Kadouri2007 ER - TY - STD TI - Berry-Kravis E, Des Portes V, Hagerman R, Jacquemont S, Charles P, Visootsak J, et al. Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Sci Transl Med. 2016;8:321ra5. ID - ref27 ER - TY - JOUR AU - Vrij, F. M. S. AU - Levenga, J. AU - Linde, H. C. AU - Koekkoek, S. K. AU - Zeeuw, C. I. AU - Nelson, D. L. PY - 2008 DA - 2008// TI - Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice JO - Neurobiol Dis VL - 31 UR - https://doi.org/10.1016/j.nbd.2008.04.002 DO - 10.1016/j.nbd.2008.04.002 ID - Vrij2008 ER - TY - JOUR AU - Pop, A. S. AU - Levenga, J. AU - Esch, C. E. AU - Buijsen, R. A. AU - Nieuwenhuizen, I. M. AU - Li, T. PY - 2014 DA - 2014// TI - Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/mavoglurant JO - Psychopharmacology (Berl) VL - 231 UR - https://doi.org/10.1007/s00213-012-2947-y DO - 10.1007/s00213-012-2947-y ID - Pop2014 ER - TY - JOUR AU - Su, T. AU - Fan, H. X. AU - Jiang, T. AU - Sun, W. W. AU - Den, W. Y. AU - Gao, M. M. PY - 2011 DA - 2011// TI - Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome JO - Psychopharmacology (Berl) VL - 215 UR - https://doi.org/10.1007/s00213-010-2130-2 DO - 10.1007/s00213-010-2130-2 ID - Su2011 ER - TY - JOUR AU - Thomas, A. AU - Bui, N. AU - Perkins, J. AU - Yuva-Paylor, L. AU - Paylor, R. PY - 2012 DA - 2012// TI - Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome JO - Psychopharmacology (Berl) VL - 219 UR - https://doi.org/10.1007/s00213-011-2375-4 DO - 10.1007/s00213-011-2375-4 ID - Thomas2012 ER - TY - JOUR AU - Yan, Q. J. AU - Rammal, M. AU - Tranfaglia, M. AU - Bauchwitz, R. P. PY - 2005 DA - 2005// TI - Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP JO - Neuropharmacology VL - 49 UR - https://doi.org/10.1016/j.neuropharm.2005.06.004 DO - 10.1016/j.neuropharm.2005.06.004 ID - Yan2005 ER - TY - JOUR AU - Michalon, A. AU - Sidorov, M. AU - Ballard, T. M. AU - Ozmen, L. AU - Spooren, W. AU - Wettstein, J. G. PY - 2012 DA - 2012// TI - Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice JO - Neuron VL - 74 UR - https://doi.org/10.1016/j.neuron.2012.03.009 DO - 10.1016/j.neuron.2012.03.009 ID - Michalon2012 ER - TY - JOUR AU - Aman, M. G. AU - Singh, N. N. AU - Stewart, A. W. AU - Field, C. J. PY - 1985 DA - 1985// TI - The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects JO - Am J Ment Defic VL - 89 ID - Aman1985 ER - TY - JOUR AU - Aman, M. G. AU - Burrow, W. H. AU - Wolford, P. L. PY - 1995 DA - 1995// TI - The Aberrant Behavior Checklist-Community: factor validity and effect of subject variables for adults in group homes JO - Am J Ment Retard VL - 100 ID - Aman1995 ER - TY - JOUR AU - Wheeler, A. AU - Raspa, M. AU - Bann, C. AU - Bishop, E. AU - Hessl, D. AU - Sacco, P. PY - 2014 DA - 2014// TI - Anxiety, attention problems, hyperactivity, and the Aberrant Behavior Checklist in fragile X syndrome JO - Am J Med Genet A VL - 164A UR - https://doi.org/10.1002/ajmg.a.36232 DO - 10.1002/ajmg.a.36232 ID - Wheeler2014 ER -